Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Scancell Holdings Plc
Biological Products Except Diagnostic Substances United Kingdom
London Stock Exchange: SCLP
Company Description
Scancell Holdings Plc develops novel therapeutic vaccines for the treatment of cancer and infectious diseases. The company's clinical candidate drug cancer vaccine SCIB1 is a plasmid DNA, which encodes a human antibody molecule engineered to express a melanoma antigen called Tyrosinase-Related Protein 2 plus two helper T cell epitopes. Scancell Holdings founded by Lindy Gillian Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.
Similar to: Retrophin Inc, Cardium Therapeutics, Inc., BioTime, Inc.
Featured Company
Goodwin Plc
Hanley, ST, GB
Goodwin Plc provides machining, general engineering, valves and Pumps. The firm operates casting, melting, refining, assembly and… Learn more →
You may also be interested in:
BioTime, Inc.
Alameda, CA, US
BioTime, Inc. is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of… Learn more →
Cardium Therapeutics, Inc.
San Diego, CA, US
Cardium Therapeutics, Inc. is an asset-based, health sciences and regenerative medicine company focused on acquiring and strategically… Learn more →
Retrophin Inc
New York, NY, US
Retrophin, Inc. (OTCQB: RTRX) New York-based, biotechnology company focused on discovering and developing treatments for rare and… Learn more →